Segment and Geographical Information (Tables)

9 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income and depreciation and amortization, as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
(Dollars in thousands)	2017			2016			2017			2016
Revenue:
Medical Device	$	12,778		$	15,654		$	39,260		$	39,500
In Vitro Diagnostics		5,012			4,318			13,794			13,712
Total revenue	$	17,790		$	19,972		$	53,054		$	53,212
Operating income:
Medical Device	$	1,403		$	6,673		$	6,627		$	12,825
In Vitro Diagnostics		2,230			1,673			5,922			5,298
Total segment operating income		3,633			8,346			12,549			18,123
Corporate		(1,890	)		(1,749	)		(5,861	)		(5,347	)
Total operating income	$	1,743		$	6,597		$	6,688		$	12,776
Depreciation and amortization:
Medical Device	$	1,132		$	982		$	3,180		$	2,440
In Vitro Diagnostics		103			222			309			647
Corporate		170			202			517			616
Total depreciation and amortization	$	1,405		$	1,406		$	4,006		$	3,703